BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim SY, Kim JE, Kim YJ, Han KS, Kim HK. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment. J Gastroenterol Hepatol 2015;30:784-93. [PMID: 25303721 DOI: 10.1111/jgh.12800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Martí-Carvajal AJ, Solà I. Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease. Cochrane Database Syst Rev 2015;:CD006007. [PMID: 26058965 DOI: 10.1002/14651858.CD006007.pub4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Graff J, Harder S. Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment. Clin Pharmacokinet 2013;52:243-54. [PMID: 23389892 DOI: 10.1007/s40262-013-0034-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 8.9] [Reference Citation Analysis]
4 Kavanagh C, Shaw S, Webster CR. Coagulation in hepatobiliary disease. J Vet Emerg Crit Care (San Antonio). 2011;21:589-604. [PMID: 22316251 DOI: 10.1111/j.1476-4431.2011.00691.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
5 Sahmeddini MA, Taghizadehimani A, Khosravi MB, Eghbal MH. Magnesium Therapy Improves Rotational Thromboelastometry Findings Prior to Liver Transplantation: A Randomized Clinical Trial. Indian J Hematol Blood Transfus 2020;36:505-11. [PMID: 32647425 DOI: 10.1007/s12288-020-01260-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Arshad F, Lisman T, Porte RJ. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int. 2013;33:820-827. [PMID: 23490221 DOI: 10.1111/liv.12140] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
7 Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesth Analg 2018;126:46-61. [PMID: 28795966 DOI: 10.1213/ANE.0000000000002394] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 10.7] [Reference Citation Analysis]
8 Parker RI. Coagulopathies in the PICU: DIC and liver disease. Crit Care Clin 2013;29:319-33. [PMID: 23537678 DOI: 10.1016/j.ccc.2012.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
9 Schmidt AE, Israel AK, Refaai MA. The Utility of Thromboelastography to Guide Blood Product Transfusion. Am J Clin Pathol 2019;152:407-22. [PMID: 31263903 DOI: 10.1093/ajcp/aqz074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
10 Martí-Carvajal AJ, Solà I, Martí-Carvajal PI. Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease. Cochrane Database Syst Rev 2012;:CD006007. [PMID: 22972089 DOI: 10.1002/14651858.CD006007.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
11 Franchini M, Zaffanello M, Mannucci PM. Bleeding Disorders in Primary Fibrinolysis. Int J Mol Sci 2021;22:7027. [PMID: 34209949 DOI: 10.3390/ijms22137027] [Reference Citation Analysis]
12 Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis. Blood Coagul Fibrinolysis 2013;24:150-6. [PMID: 23314386 DOI: 10.1097/MBC.0b013e32835aef6b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Singh S, Nasa V, Tandon M. Perioperative monitoring in liver transplant patients. J Clin Exp Hepatol 2012;2:271-8. [PMID: 25755443 DOI: 10.1016/j.jceh.2012.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Aloia TA, Geerts WH, Clary BM, Day RW, Hemming AW, D’albuquerque LC, Vollmer CM, Vauthey J, Toogood GJ. Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg 2016;20:221-9. [DOI: 10.1007/s11605-015-2902-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
15 Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood 2018;131:845-54. [DOI: 10.1182/blood-2017-10-804096] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 29.0] [Reference Citation Analysis]
16 Budnick IM, Davis JPE, Sundararaghavan A, Konkol SB, Lau CE, Alsobrooks JP, Stotts MJ, Intagliata NM, Lisman T, Northup PG. Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients. Thromb Haemost 2021. [PMID: 33450778 DOI: 10.1055/a-1355-3716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zahr Eldeen F, Roll GR, Derosas C, Rao R, Khan MS, Gunson BK, Hodson J, Mergental H, Ferraz-Neto BH, Isaac J, Muiesan P, Mirza DF, Iqbal A, Perera MT. Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation. Transplantation. 2016;100:2382-2390. [PMID: 27780186 DOI: 10.1097/tp.0000000000001395] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
18 Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl. 2013;19:852-861. [PMID: 23696318 DOI: 10.1002/lt.23668] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 10.3] [Reference Citation Analysis]
19 Tomkiewicz-pajak L, Wojcik T, Chłopicki S, Olszowska M, Pajak J, Podolec J, Sitek B, Musiałek P, Rubis P, Komar M, Podolec P. Aspirin resistance in adult patients after Fontan surgery. International Journal of Cardiology 2015;181:19-26. [DOI: 10.1016/j.ijcard.2014.11.219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
20 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Reference Citation Analysis]
21 Aguilar C. Potential usefulness of thrombopoietin receptor agonists in haemophiliacs with thrombocytopaenia due to chronic liver disease. Blood Coagul Fibrinolysis. 2013;24:231-236. [PMID: 23518832 DOI: 10.1097/MBC.0b013e3283606a0b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Macivor D, Rebel A, Hassan Z. How do we integrate thromboelastography with perioperative transfusion management?: INTEGRATING TEG WITH TRANSFUSION MANAGEMENT. Transfusion 2013;53:1386-92. [DOI: 10.1111/j.1537-2995.2012.03728.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Marks PW. Hematologic manifestations of liver disease. Semin Hematol 2013;50:216-21. [PMID: 23953338 DOI: 10.1053/j.seminhematol.2013.06.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
24 Agarwal A, Sharma N, Vij V. Point-of-care coagulation monitoring during liver transplantation. Trends in Anaesthesia and Critical Care 2013;3:42-8. [DOI: 10.1016/j.tacc.2012.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Zhou J, Mao W, Shen L, Huang H. Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis. Medicine (Baltimore) 2019;98:e18527. [PMID: 31876748 DOI: 10.1097/MD.0000000000018527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Morrow GB, Beavis J, Harper S, Baker P, Desborough MJR, Curry N, Stanworth SJ, Laffan MA. Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyzer. J Thromb Haemost 2020;18:1576-85. [PMID: 32196929 DOI: 10.1111/jth.14802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
27 Townsend JC, Heard R, Powers ER, Reuben A. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol. 2012;110:1062-1065. [PMID: 22728001 DOI: 10.1016/j.amjcard.2012.05.043] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
28 Hong C, Scobey M, Napenas J, Brennan M, Lockhart P. Dental postoperative bleeding complications in patients with suspected and documented liver disease: Bleeding in patient with liver disease. Oral Diseases 2012;18:661-6. [DOI: 10.1111/j.1601-0825.2012.01922.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
29 Kujovich JL. Coagulopathy in liver disease: a balancing act. Hematology Am Soc Hematol Educ Program. 2015;2015:243-249. [PMID: 26637729 DOI: 10.1182/asheducation-2015.1.243] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
30 Rijken DC, Kock EL, Guimarães AH, Talens S, Darwish Murad S, Janssen HL, Leebeek FW. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J Thromb Haemost 2012;10:2116-22. [PMID: 22906184 DOI: 10.1111/j.1538-7836.2012.04901.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
31 Leung CC, Young KK. Clinical aspects of hepatic disease. Anaesthesia & Intensive Care Medicine 2015;16:11-3. [DOI: 10.1016/j.mpaic.2014.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Franchini M, Mannucci PM. Primary hyperfibrinolysis: Facts and fancies. Thromb Res. 2018;166:71-75. [PMID: 29665524 DOI: 10.1016/j.thromres.2018.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
33 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Int J Hepatol 2011;2011:759047. [PMID: 21994870 DOI: 10.4061/2011/759047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
34 Lu C, White SJ, Ye IB, Mikhail CM, Cheung ZB, Cho SK. The Effects of Liver Disease on Surgical Outcomes Following Adult Spinal Deformity Surgery. World Neurosurg 2019;130:e498-504. [PMID: 31254688 DOI: 10.1016/j.wneu.2019.06.137] [Reference Citation Analysis]
35 Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22. [PMID: 23815798 DOI: 10.1186/1471-2482-13-22] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
36 Levi M. Pathogenesis and diagnosis of disseminated intravascular coagulation. Int J Lab Hematol 2018;40 Suppl 1:15-20. [PMID: 29741245 DOI: 10.1111/ijlh.12830] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 14.7] [Reference Citation Analysis]
37 Baltatzis M, Low R, Stathakis P, Sheen AJ, Siriwardena AK, Jamdar S. Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: a systematic review and meta-analysis. HPB (Oxford) 2017;19:289-96. [PMID: 28162922 DOI: 10.1016/j.hpb.2017.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
38 Aggarwal A, Puri K, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhotic patients: Systematic review. World J Gastroenterol 2014; 20(19): 5737-5745 [PMID: 24914335 DOI: 10.3748/wjg.v20.i19.5737] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
39 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Potpara TS, Lip GY. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. Prog Cardiovasc Dis 2015;58:177-94. [PMID: 26162958 DOI: 10.1016/j.pcad.2015.07.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
41 Esmat Gamil M, Pirenne J, Van Malenstein H, Verhaegen M, Desschans B, Monbaliu D, Aerts R, Laleman W, Cassiman D, Verslype C, Van Steenbergen W, Van Pelt J, Nevens F. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation. Transplant Proc 2012;44:2857-60. [PMID: 23146542 DOI: 10.1016/j.transproceed.2012.09.085] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
42 De Santis GC, Brunetta DM, Nardo M, Oliveira LC, Souza FF, Cagnolati D, Mente ÊD, Sankarankutty AK, Covas DT, de Castro e Silva O. Preoperative variables associated with transfusion requirements in orthotopic liver transplantation. Transfus Apher Sci 2014;50:99-105. [PMID: 24291115 DOI: 10.1016/j.transci.2013.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
43 Bonnet N, Paul J, Helleputte T, Veyckemans F, Pirotte T, Prégardien C, Eeckhoudt S, Hermans C, Detaille T, Clapuyt P, Menten R, Dumitriu D, Reding R, Scheers I, Varma S, Smets F, Sokal E, Stéphenne X. Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children. Pediatr Transplant 2019;23:e13390. [PMID: 30888111 DOI: 10.1111/petr.13390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Cho J, Choi SM, Yu SJ, Park YS, Lee CH, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Lee J. Bleeding complications in critically ill patients with liver cirrhosis. Korean J Intern Med 2016;31:288-95. [PMID: 26805633 DOI: 10.3904/kjim.2014.152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
45 Sinegre T, Duron C, Lecompte T, Pereira B, Massoulier S, Lamblin G, Abergel A, Lebreton A. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. J Thromb Haemost. 2018;16:1132-1140. [PMID: 29577605 DOI: 10.1111/jth.14011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
46 Sabate A, Dalmau A, Koo M, Aparicio I, Costa M, Contreras L. Coagulopathy management in liver transplantation. Transplant Proc. 2012;44:1523-1525. [PMID: 22841202 DOI: 10.1016/j.transproceed.2012.05.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
47 De Santis GC, Prata KL, Rodrigues RB, Sankarankutty AK, de Castro e Silva O, Covas DT. Blood group O patients require more blood transfusion in orthotopic liver transplantation. Transfus Apher Sci 2014;50:312-3. [PMID: 24485953 DOI: 10.1016/j.transci.2014.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Retter A, Barrett NA. The management of abnormal haemostasis in the ICU. Anaesthesia 2015;70:121-e41. [DOI: 10.1111/anae.12908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
49 Talon L, Sinegre T, Lecompte T, Pereira B, Massoulié S, Abergel A, Lebreton A. Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST‐Genesia. J Thromb Haemost 2020;18:2177-90. [DOI: 10.1111/jth.14963] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
50 Horsley-Silva JL, Vargas HE. Gastrointestinal endoscopy in the cirrhotic patient. Expert Rev Gastroenterol Hepatol. 2015;9:1005-1013. [PMID: 25967459 DOI: 10.1586/17474124.2015.1044978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Yang ZJ, Costa KA, Novelli EM, Smith RE. Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost 2014;20:169-78. [PMID: 23076776 DOI: 10.1177/1076029612461846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
52 Tengborn L, Blombäck M, Berntorp E. Tranexamic acid--an old drug still going strong and making a revival. Thromb Res. 2015;135:231-242. [PMID: 25559460 DOI: 10.1016/j.thromres.2014.11.012] [Cited by in Crossref: 134] [Cited by in F6Publishing: 112] [Article Influence: 19.1] [Reference Citation Analysis]
53 Quinn JG, Tansey EA, Johnson CD, Roe SM, Montgomery LEA. Blood: tests used to assess the physiological and immunological properties of blood. Advances in Physiology Education 2016;40:165-75. [DOI: 10.1152/advan.00079.2015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
54 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
55 Kolev K, Longstaff C. Bleeding related to disturbed fibrinolysis. Br J Haematol 2016;175:12-23. [PMID: 27477022 DOI: 10.1111/bjh.14255] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 10.4] [Reference Citation Analysis]